Loading Events

Thank You For Attending Today’s Webinar

Please tell us what you thought about today’s presentation by taking the survey below:

Unmet Needs In Agitation Associated With Alzheimer’s Dementia

This is a Virtual Event for PsychU members in Arizona, Colorado, Nevada, New Mexico, Wyoming and El Paso, Texas.

This evidence-based review highlights important aspects of agitation associated with Alzheimer’s Dementia (AAD) for better understanding of the prevalence and challenges in diagnosis and explore the potential pathobiological correlations in AAD. Describes the clinical and humanistic burden and discusses current guidelines for nonpharmacological and pharmacological treatments of this complex and prominent complication of an already devastating disease. It underlines unmet needs for FDA-approved pharmaceutical treatments for agitation to improve care and quality of life for patients suffering from AAD.

Featuring

Jessie-Chambers

Jessie Chambers, PhD

Medical Science Liaison

Laura-Brennan

Laura Brennan, PhD (OPDC)

Medical Science Liaison

Speakers Jessie Chambers, PhD and Laura Brennan, PhD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Registration

Related Resources